Jack Cuzick1,2,3,4,5,6,7,8,9,10, Mitch Dowsett1,2,3,4,5,6,7,8,9,10, Sílvia Pineda1,2,3,4,5,6,7,8,9,10, Chris Wale1,2,3,4,5,6,7,8,9,10, Janine Salter1,2,3,4,5,6,7,8,9,10, Emma M. Quinn1,2,3,4,5,6,7,8,9,10, Lila Zabaglo1,2,3,4,5,6,7,8,9,10, Elizabeth Mallon1,2,3,4,5,6,7,8,9,10, Andrew R. Green1,2,3,4,5,6,7,8,9,10, Ian O. Ellis1,2,3,4,5,6,7,8,9,10, Anthony Howell1,2,3,4,5,6,7,8,9,10, Aman U. Buzdar1,2,3,4,5,6,7,8,9,10, John Forbes1,2,3,4,5,6,7,8,9,10
1Centre for Cancer Prevention, Wolf-son Institute of Preventive Medicine, Queen Mary University of London;
2Jack Cuzick, Silvia Pineda, and Christopher Wale, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London; Mitch Dowsett, Janine Salter, Emma Quinn, and Lila Zabaglo, Royal Marsden Hospital, London; Elizabeth Mallon, Western Infirmary, North Glasgow University Hospital, Glasgow; Andrew R. Green and Ian O. Ellis, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals National Health Services Trust, City Hospital,...
3Manchester Breast Centre and Break-through Breast Cancer Research Unit, Manchester, United Kingdom;
4North Glasgow University Hospital, Glasgow;
5Nottingham City Hospital, Nottingham
6Nottingham University Hospitals National Health Services Trust, City Hospital,
7Royal Marsden Hospital, London
8School of Molecular Medical Sciences, University of Nottingham and
9The University of Texas MD Ander-son Cancer Center, Houston, TX;
10University of Newcastle, School of Medical Practice and Population Health, Callaghan, New South Wales, Australia.
